Source: https://www.atlangram.com/en/publications.html
Timestamp: 2019-04-25 12:21:45+00:00

Document:
Impact of bacterial biofilm on the treatment of prosthetic joint infections. C. Jacqueline and J. Caillon. J. Antimicrob Chemother, Journal of Antimicrobial Chemotherapy. 09/2014; 69 Suppl 1:i37-i40.
Linezolid Dampens Neutrophil-Mediated Inflammation in Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia and Protects the Lung of Associated Damages. Cédric Jacqueline, Alexis Broquet, Antoine Roquilly, Marion Davieau, Jocelyne Caillon, Frédéric Altare, Gilles Potel, Karim Asehnoune. J Infect Dis. 2014 Apr 10.
50% Effective dose (ED50) Determination of KPI-10 for Treating Sepsis in Mice Due to Fluoroquinolone-Susceptible (FQ-S) and Fluoroquinolone-Resistant (FQ-R) Nosocomial Pathogens: Comparison with Ciprofloxacin (CIP). C. Jacqueline, M. Davieau, C. Desessard, A.F. Miègeville, Y. Ge, G. Potel, J. Caillon. ICAAC 2012. Poster n° F-2056.
In Vitro Bactericidal Activity of KPI-10, a Next Generation Fluoroquinolone (FQ), Against FQ-Susceptible (FQ-S) and FQ-Resistant (FQ-R) Gram-Negative and Gram-Positive Isolates. C. Jacqueline, C. Desessard, M. Davieau, A.F. Miègeville, Y. Ge, G. Potel, J. Caillon. ICAAC 2012. Poster n° E-203.
Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response. C. Jacqueline, A. Roquilly, C. Desessard, D. Boutoille, A. B. V. Le Mabecque, G. Amador, G. Potel, J. Caillon and K. Asehnoune. J. Antimicrob Chemother, 2012 Aug.
Systemic Exposure Profile and Tissue Penetration (Lung, Kidney, Bone Marrow, and Gallblader) in Rabbits After KPI-10 Intravenous Administration. C. Jacqueline, V. Le Mabecque, C. Desessard, A.F. Miègeville, Y. Ge, G. Potel, J. Caillon. ICAAC 2012. Poster n° A-1948.
Efficacy of ceftaroline fosamil in combination with the non-beta-lactam beta-lactamase inhibitor avibactam against ampC-producing Enterobacter cloacae: comparative study with doripenem in a rabbit experimental endocarditis model. C. Jacqueline, C. Bretonniere, V. Le Mabecque, C. Desessard, G. Amador, A.F. Miegeville, G. Williams, G. Potel, J. Caillon. ECCMID 2012. n° P 2065.
Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia. C. Bretonnière, C. Jacqueline, J. Caillon, C. Guitton, C. Desessard, V. Le Mabecque, A.F. Miégeville, D. Villers, G. Potel, D. Boutoille. J Antimicrob Chemother. 2012 Mar;67(3): 780-1.
﻿In Vivo Activity of CXA-101 Against Pseudomonas aeruginosa(PA) in a Rabbit Experimental Model of Pneumonia: Comparison with Ceftazidime (CAZ), Piperacillin/Tazobactam (TZP), and Imipenem (IMP). C. Jacqueline, C. Bretonniere, C. Desessard, V. Le Mabecque, D. Boutoille, G. Potel, J. Caillon. ICAAC 2011. Poster n° B-590.
Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. Bretonnière C, Jacqueline C, Caillon J, Guitton C, Le Mabecque V, Miégeville AF, Villers D, Potel G, Boutoille D. J Antimicrob Chemother. 2010 Nov; 65 (11): 2423-7.
ED50 Determination of CXA-101 Alone and in Combination with Tazobactam (TAZ) for Treating Experimental Peritonitis in Mice Due to ESBL-Producing Klebsiella pneumonia (KP) Strains: Comparison with Ceftazidime (CAZ) and Piperacillin/Tazobactam (TZP). C. Jacqueline, C. Desessard, G. Amador, E. Batard, A. F. Miegeville, J. Y. Ge, G. Potel , J. Caillon. ICAAC 2010. Poster n° B-708.
Assessment of the In Vivo Activity of CXA-101 in a Murine Model of Pseudomonas aeruginosa Pneumonia: Comparison with Ceftazidime and Piperacillin-Tazobactam. C. Jacqueline, C. Desessard, A. Roquilly, V. Le Mabecque, D. Boutoile, J. Y. Ge, K. Asehnoune , J. Caillon, G. Potel. ICAAC 2010. Poster n° B-1401.
Efficacy of Daptomycin Against Staphylococcus epidermidis in an In Vitro-Infected Fibrin Clot Model: Comparison with Vancomycin. M. Briere, J. Caillon, C. Jacqueline, A. F. Miegeville, G. Potel , E. Batard. ICAAC 2010. Poster n° E-1553.
Influence of the AtlE autolysin on the activity of cell wall-active agents against Staphylococcus epidermidis. Hello M, Caroff N, Jacqueline C, Caillon J, Potel G, Batard E. Int J Antimicrob Agents. 2010 Feb;35(2):204-6.
FIC Index Determination of CXA-101 (CXA)/Tazobactam (TAZ) in Combination with Amikacin (AMK), Aztreonam (ATM), Meropenem (MEM), Levofloxacin (LVX), and Tigecycline (TGC) against Escherichia coli (EC), Klebsiella pneumoniae (KP), and Pseudomonas aeruginosa (PA) Strains. C. Jacqueline, C. Desessard, Y. Ge, G. Potel, J. Caillon. ICAAC 2009. Poster n° F1-1995.
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model. Hamel A, Caillon J, Jacqueline C, Batard E, Potel G. Int J Antimicrob Agents. 2008 Feb; 31(2): 158-60.
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G. Antimicrob Agents Chemother. 2007 Sep; 51 (9): 3397-400.
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. Jacqueline C, Caillon J, Grossi O, Le Mabecque V, Miegeville AF, Bugnon D, Batard E, Potel G. Antimicrob Agents Chemother. 2006 Jul; 50 (7): 2547-9.
Eagle effect in Corynebacterium diphtheriae. Grandière-Pérez L, Jacqueline C, Lemabecque V, Patey O, Potel G, Caillon J. J Infect Dis. 2005 Jun 15; 191 (12): 2118-20.
Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy. Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J. Antimicrob Agents Chemother. 2005 Feb; 49 (2): 857-9.
In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus. Jacqueline C, Navas D, Batard E, Miegeville AF, Le Mabecque V, Kergueris MF, Bugnon D, Potel G, Caillon J. Antimicrob Agents Chemother. 2005 Jan; 49 (1): 45-51.
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics. Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bugnon D, Potel G. J Antimicrob Chemother. 2004 Oct; 54 (4): 767-71.
In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Jacqueline C, Asseray N, Batard E, Le Mabecque V, Kergueris MF, Dube L, Bugnon D, Potel G, Caillon J. Int J Antimicrob Agents. 2004 Oct; 24 (4): 393-6.
Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. Dubé L, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Granry JC, Potel G, Bugnon D. Antimicrob Agents Chemother. 2003 Nov; 47 (11): 3663-6.
In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Jacqueline C, Batard E, Perez L, Boutoille D, Hamel A, Caillon J, Kergueris MF, Potel G, Bugnon D. Antimicrob Agents Chemother. 2002 Dec; 46 (12): 3706-11.
In vivo activity of amoxicillin in a non-toxigenic Corynebacterium diphtheriae rabbit endocarditis experimental model. Grandière-Perez L, Jacqueline C, Le Mabecque V, Patey O, Potel G, Bugnon D, Caillon J. Pathol Biol (Paris). 2002 Nov; 50 (9): 513-5.
Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study. Batard E, Jacqueline C, Boutoille D, Hamel A, Drugeon HB, Asseray N, Leclercq R, Caillon J, Potel G, Bugnon D. Antimicrob Agents Chemother. 2002 Jul; 46 (7): 2174-8.
Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Asseray N, Caillon J, Roux N, Jacqueline C, Bismuth R, Kergueris MF, Potel G, Bugnon D. Antimicrob Agents Chemother. 2002 May; 46 (5): 1591-3.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V.